WCM Investment Management LLC purchased a new position in shares of Dolby Laboratories (NYSE:DLB – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,287 shares of the electronics maker’s stock, valued at approximately $716,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Royal Bank of Canada lifted its holdings in Dolby Laboratories by 3.5% during the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock worth $5,491,000 after buying an additional 2,298 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock worth $20,043,000 after acquiring an additional 171,288 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Dolby Laboratories by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock worth $19,131,000 after acquiring an additional 12,598 shares in the last quarter. Focus Partners Wealth purchased a new stake in shares of Dolby Laboratories during the first quarter worth $390,000. Finally, EverSource Wealth Advisors LLC increased its position in shares of Dolby Laboratories by 273.3% during the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after acquiring an additional 1,902 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Analysts Set New Price Targets
A number of research firms recently issued reports on DLB. Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a report on Monday, June 15th. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research report on Thursday, June 11th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.
Insiders Place Their Bets
In other news, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $54.90, for a total value of $164,700.00. Following the transaction, the senior vice president owned 80,603 shares in the company, valued at approximately $4,425,104.70. This represents a 3.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CMO Todd Pendleton sold 11,876 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $54.55, for a total value of $647,835.80. Following the sale, the chief marketing officer directly owned 41,480 shares in the company, valued at $2,262,734. This trade represents a 22.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 47,458 shares of company stock valued at $2,639,537 over the last quarter. Corporate insiders own 37.93% of the company’s stock.
Dolby Laboratories Trading Down 1.5%
Shares of NYSE:DLB opened at $49.91 on Wednesday. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $77.00. The company’s 50 day moving average is $52.66 and its two-hundred day moving average is $59.23. The company has a market cap of $4.72 billion, a PE ratio of 19.73 and a beta of 0.81.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The business had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company’s revenue was up 7.0% on a year-over-year basis. During the same period last year, the business earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, equities research analysts expect that Dolby Laboratories will post 3.21 EPS for the current year.
Dolby Laboratories Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.9%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 56.92%.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
